Stockreport

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema [Yahoo! Finance]

Oculis Holding AG - Ordinary shares  (OCS) 
PDF Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites worldwide primarily in the US; topline data r [Read more]